Cargando…
p53 Is a Key Regulator for Osthole-Triggered Cancer Pathogenesis
Osthole has been reported to have antitumor activities via the induction of apoptosis and inhibition of cancer cell growth and metastasis. However, the detailed molecular mechanisms underlying the anticancer effects of osthole in human colon cancer remain unclear. In the present study, we have asses...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075183/ https://www.ncbi.nlm.nih.gov/pubmed/25013761 http://dx.doi.org/10.1155/2014/175247 |
_version_ | 1782323299421782016 |
---|---|
author | Huang, Ssu-Ming Tsai, Cheng-Fang Chen, Dar-Ren Wang, Min-Ying Yeh, Wei-Lan |
author_facet | Huang, Ssu-Ming Tsai, Cheng-Fang Chen, Dar-Ren Wang, Min-Ying Yeh, Wei-Lan |
author_sort | Huang, Ssu-Ming |
collection | PubMed |
description | Osthole has been reported to have antitumor activities via the induction of apoptosis and inhibition of cancer cell growth and metastasis. However, the detailed molecular mechanisms underlying the anticancer effects of osthole in human colon cancer remain unclear. In the present study, we have assessed osthole-induced cell death in two different human colon cancer cell lines, HCT116 and SW480. Our results also showed that osthole activated proapoptotic signaling pathways in human colon cancer cells. By using cell culture insert system, osthole reduced cell motility in both human colon cancer cell lines. This study also provides evidence supporting the potential of osthole in p53 activation. Expression of p53, an apoptotic protein, was remarkably upregulated in cells treated with osthole. Importantly, the levels of phosphorylation of p53 on Ser15 (p-p53) and acetylation of p53 on Lys(379) (acetyl-p53) were increased under osthole treatment. Our results also demonstrated that p53 was activated followed by generation of reactive oxygen species (ROS) and activation of c-Jun N-terminal kinase (JNK). Our study provides novel insights of p53-mediated responses under osthole treatment. Taken together, we concluded that osthole induces cancer cell death and inhibits migratory activity in a controlled manner and is a promising candidate for antitumor drug development. |
format | Online Article Text |
id | pubmed-4075183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-40751832014-07-10 p53 Is a Key Regulator for Osthole-Triggered Cancer Pathogenesis Huang, Ssu-Ming Tsai, Cheng-Fang Chen, Dar-Ren Wang, Min-Ying Yeh, Wei-Lan Biomed Res Int Research Article Osthole has been reported to have antitumor activities via the induction of apoptosis and inhibition of cancer cell growth and metastasis. However, the detailed molecular mechanisms underlying the anticancer effects of osthole in human colon cancer remain unclear. In the present study, we have assessed osthole-induced cell death in two different human colon cancer cell lines, HCT116 and SW480. Our results also showed that osthole activated proapoptotic signaling pathways in human colon cancer cells. By using cell culture insert system, osthole reduced cell motility in both human colon cancer cell lines. This study also provides evidence supporting the potential of osthole in p53 activation. Expression of p53, an apoptotic protein, was remarkably upregulated in cells treated with osthole. Importantly, the levels of phosphorylation of p53 on Ser15 (p-p53) and acetylation of p53 on Lys(379) (acetyl-p53) were increased under osthole treatment. Our results also demonstrated that p53 was activated followed by generation of reactive oxygen species (ROS) and activation of c-Jun N-terminal kinase (JNK). Our study provides novel insights of p53-mediated responses under osthole treatment. Taken together, we concluded that osthole induces cancer cell death and inhibits migratory activity in a controlled manner and is a promising candidate for antitumor drug development. Hindawi Publishing Corporation 2014 2014-06-12 /pmc/articles/PMC4075183/ /pubmed/25013761 http://dx.doi.org/10.1155/2014/175247 Text en Copyright © 2014 Ssu-Ming Huang et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Huang, Ssu-Ming Tsai, Cheng-Fang Chen, Dar-Ren Wang, Min-Ying Yeh, Wei-Lan p53 Is a Key Regulator for Osthole-Triggered Cancer Pathogenesis |
title | p53 Is a Key Regulator for Osthole-Triggered Cancer Pathogenesis |
title_full | p53 Is a Key Regulator for Osthole-Triggered Cancer Pathogenesis |
title_fullStr | p53 Is a Key Regulator for Osthole-Triggered Cancer Pathogenesis |
title_full_unstemmed | p53 Is a Key Regulator for Osthole-Triggered Cancer Pathogenesis |
title_short | p53 Is a Key Regulator for Osthole-Triggered Cancer Pathogenesis |
title_sort | p53 is a key regulator for osthole-triggered cancer pathogenesis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4075183/ https://www.ncbi.nlm.nih.gov/pubmed/25013761 http://dx.doi.org/10.1155/2014/175247 |
work_keys_str_mv | AT huangssuming p53isakeyregulatorforostholetriggeredcancerpathogenesis AT tsaichengfang p53isakeyregulatorforostholetriggeredcancerpathogenesis AT chendarren p53isakeyregulatorforostholetriggeredcancerpathogenesis AT wangminying p53isakeyregulatorforostholetriggeredcancerpathogenesis AT yehweilan p53isakeyregulatorforostholetriggeredcancerpathogenesis |